Keywords: gsk, increase, relenza, production, uk, drug, major

GSK to increase Relenza production

Article | 06 February 2006

Print This

UK drug major GlaxoSmithKline says it will increase its Relenza (zanamivir) manufacturing capacity to meet increased public demand for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in